Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 8Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Stomach Neoplasms 7Rectal Neoplasms 5Nasopharyngeal Carcinoma 5Colorectal Neoplasms 5Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Pancreatic Neoplasms 3Melanoma 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Endometrial Neoplasms 2Carcinoma, Renal Cell 2Advanced Solid Tumor 2Triple Negative Breast Neoplasms 1Squamous Cell Non-small Cell Lung Cancer 1Solid Tumor, Adult 1Solid Tumor 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms by Site 1

Interventions

Nivolumab 28pembrolizumab 24cabozantinib 22Ipilimumab 19Specimen Handling 14Magnetic Resonance Spectroscopy 13Axitinib 12lenvatinib 10Radiosurgery 9belzutifan 8CTLA-4 Antigen 7Biopsy 7atezolizumab 6cemiplimab 5Radiotherapy 5Bevacizumab 5toripalimab 4Everolimus 4Blood Specimen Collection 4avelumab 3aldesleukin 3X-Rays 3Sunitinib 3Standard of Care 3Paclitaxel 3zimberelimab 2trastuzumab deruxtecan 2tivozanib 2spartalizumab 2pazopanib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Renal Cell × spartalizumab × Clear all
NCT07571551 2026-05-11

TRIPLE-PATH

Jinling Hospital, China

Phase 2 Recruiting
75 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT06255223 2025-09-03

A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy

Jinling Hospital, China

Phase 2 Recruiting
35 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡